SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 68 filers reported holding SYNERON MEDICAL LTD in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,283,000 | -23.4% | 208,434 | -26.2% | 0.00% | -50.0% |
| Q1 2017 | $2,979,000 | +2.2% | 282,387 | -18.5% | 0.00% | 0.0% |
| Q4 2016 | $2,915,000 | +21.0% | 346,497 | +2.9% | 0.00% | +100.0% |
| Q3 2016 | $2,410,000 | -32.5% | 336,596 | -27.5% | 0.00% | -50.0% |
| Q2 2016 | $3,570,000 | +2.0% | 464,194 | -3.1% | 0.00% | 0.0% |
| Q1 2016 | $3,501,000 | -14.6% | 478,984 | -9.9% | 0.00% | 0.0% |
| Q4 2015 | $4,098,000 | +36.6% | 531,534 | +26.6% | 0.00% | 0.0% |
| Q3 2015 | $3,001,000 | -1.1% | 419,751 | +46.9% | 0.00% | 0.0% |
| Q2 2015 | $3,034,000 | +18.1% | 285,704 | +37.7% | 0.00% | +100.0% |
| Q1 2015 | $2,569,000 | +32.7% | 207,521 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,936,000 | +20.2% | 207,521 | +29.1% | 0.00% | 0.0% |
| Q3 2014 | $1,611,000 | +161000.0% | 160,781 | +133884.2% | 0.00% | – |
| Q2 2013 | $1,000 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Senvest Management, LLC | 2,988,261 | $25,759,000 | 2.86% |
| NORTH TIDE CAPITAL, LLC | 2,150,000 | $18,533,000 | 1.94% |
| HOURGLASS CAPITAL, LLC | 838,900 | $7,231,000 | 1.26% |
| Baupost Group | 4,000,000 | $34,480,000 | 0.98% |
| DAFNA Capital Management LLC | 90,947 | $784,000 | 0.86% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 573,108 | $4,940,000 | 0.77% |
| Visium Asset Management, LP | 3,405,000 | $29,351,000 | 0.67% |
| PERRITT CAPITAL MANAGEMENT INC | 380,000 | $3,276,000 | 0.64% |
| Leonard Capital Management, Inc. | 112,109 | $966,000 | 0.38% |
| BRANDES INVESTMENT PARTNERS, LP | 1,765,018 | $15,214,000 | 0.20% |